Cargando…
Design and Synthesis of Vandetanib Derivatives Containing Nitroimidazole Groups as Tyrosine Kinase Inhibitors in Normoxia and Hypoxia
Sixteen novel epidermal growth factor receptor (EGFR)/vascular endothelial growth factor (VEGF)-2 inhibitors (nitroimidazole-substituted 4-anilinoquinazoline derivatives (16a–p)) were designed and prepared via the introduction of a nitroimidazole group in the piperidine side chain and modification o...
Autores principales: | Wei, Huiqiang, Li, Deguan, Yang, Xiangbo, Shang, Haihua, Fan, Saijun, Li, Yiliang, Song, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273768/ https://www.ncbi.nlm.nih.gov/pubmed/27983649 http://dx.doi.org/10.3390/molecules21121693 |
Ejemplares similares
-
Design, synthesis, and biological study of 4-[(2-nitroimidazole-1H-alkyloxyl)aniline]-quinazolines as EGFR inhibitors exerting cytotoxicities both under normoxia and hypoxia
por: Cheng, Weiyan, et al.
Publicado: (2019) -
Proliferation of Ewing sarcoma cell lines is suppressed by the receptor tyrosine kinase inhibitors gefitinib and vandetanib
por: Andersson, Mattias K, et al.
Publicado: (2008) -
Vandetanib
por: Vozniak, J. Michael, et al.
Publicado: (2012) -
Substrate oxidation and the influence of breakfast in normobaric hypoxia and normoxia
por: Griffiths, Alex, et al.
Publicado: (2019) -
Gliflozins, Erythropoietin, and Erythrocytosis: Is It Renal Normoxia- or Hypoxia-Driven?
por: Heyman, Samuel N., et al.
Publicado: (2023)